Effects of antiarrhythmic drugs on QT interval dispersion--relationship to antiarrhythmic action and proarrhythmia
- PMID: 10768315
- DOI: 10.1053/pcad.2000.0420385
Effects of antiarrhythmic drugs on QT interval dispersion--relationship to antiarrhythmic action and proarrhythmia
Abstract
Class IA, IC, and III antiarrhythmic drugs prolong ventricular repolarization (VR) which is manifest as QT interval prolongation on the surface electrocardiogram. These drugs may prolong VR in a spatially heterogeneous manner which results in increased dispersion of VR. This may be manifest as increased QT interval dispersion. Antiarrhythmic drug-induced decreases in QT interval dispersion are associated with antiarrhythmic efficacy in patients with the long QT syndrome and in patients with sustained ventricular tachycardia. Antiarrhythmic drug-induced increases in QT interval dispersion are associated with ventricular proarrhythmia secondary to torsades de points ventricular tachycardia. A number of factors may modulate the effects of antiarrhythmic drugs on dispersion of VR, including the disease state, transient ischemia, electrolyte abnormalities, changes in autonomic tone, and hemodynamic stress.
Similar articles
-
Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.J Cardiovasc Electrophysiol. 2007 Jun;18(6):658-64. doi: 10.1111/j.1540-8167.2007.00813.x. J Cardiovasc Electrophysiol. 2007. PMID: 17521304
-
Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.Europace. 2007 Sep;9 Suppl 4:iv37-44. doi: 10.1093/europace/eum169. Europace. 2007. PMID: 17766322 Review.
-
[The pro-arrhythmic effects of anti-arrhythmia agents].Z Kardiol. 1994;83 Suppl 5:75-85. Z Kardiol. 1994. PMID: 7846949 Review. German.
-
Drug-induced QT prolongation and proarrhythmia: an inevitable link?Europace. 2007 Sep;9 Suppl 4:iv16-22. doi: 10.1093/europace/eum167. Europace. 2007. PMID: 17766320 Review.
-
Drug-induced QT-interval prolongation: considerations for clinicians.Pharmacotherapy. 2010 Jul;30(7):684-701. doi: 10.1592/phco.30.7.684. Pharmacotherapy. 2010. PMID: 20575633 Review.
Cited by
-
QT prolongation with antimicrobial agents: understanding the significance.Drugs. 2004;64(10):1091-124. doi: 10.2165/00003495-200464100-00005. Drugs. 2004. PMID: 15139788 Review.
-
Effects of azithromycin on ventricular repolarization in children with COVID-19.Rev Port Cardiol. 2022 Jul;41(7):551-556. doi: 10.1016/j.repc.2021.04.008. Epub 2022 Feb 21. Rev Port Cardiol. 2022. PMID: 35221464 Free PMC article.
-
Precordial QT dispersion does not predict inducibility of ventricular tachyarrhythmias at post-revascularization electrophysiologic study.J Interv Card Electrophysiol. 2002 Feb;6(1):25-33. doi: 10.1023/a:1014120105686. J Interv Card Electrophysiol. 2002. PMID: 11839880
-
The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia.Pharmaceuticals (Basel). 2021 Oct 20;14(11):1065. doi: 10.3390/ph14111065. Pharmaceuticals (Basel). 2021. PMID: 34832847 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources